Hematological disorders underlie a small proportion of all ischemic st
rokes. The association of these coagulation abnormalities with ischemi
c stroke is not always clear. The etiology of stroke still remains unc
ertain in a large number of cases and proper screening for coagulation
abnormalities and the discovery of new coagulation disorders will pro
bably increase the rate of strokes attributable to these causes. Since
large case-control studies with unselected and consecutive stroke pat
ients from different ethnic origins have not yet been performed to det
ermine the role of coagulation abnormalities in ischemic stroke, our k
nowledge is dependent on case reports and small series of mostly young
er patients. Extensive hematologic evaluation of unselected stroke pat
ients will likely yield little useful information and be too expensive
. Every stroke patient needs a careful evaluation, and in selected cas
es, this should include coagulation parameters. Patients with unexplai
ned strokes after a careful evaluation, previous thrombotic episodes,
or a positive family history for thrombosis, are good candidates for f
urther coagulation studies. As long as the hypercoagulable state persi
sts, both arterial and venous thromboembolic recurrences can be expect
ed. Many of these patients may benefit from anticoagulants. In patient
s with hereditary coagulation disorders, studies should be extended to
close relatives. Since some coagulation tests are fairly expensive, p
rovide only equivocal data, and are not widely available, we advise a
step-by-step approach starting with the patient and family history.